SHSE:600613'
s Interest Coverage Range Over the Past 10 Years
Min: 2.29 Med: 10.75 Max: 43.45
Current: 11.08
SHSE:600613's Interest Coverage is ranked worse than 52.7% of 685
companies
in the Drug Manufacturers industry
Industry Median: 12.75
vs SHSE:600613: 11.08
Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Shanghai Shenqi Pharmaceutical Investment Management Co Interest Coverage Related Terms
Shanghai Shenqi Pharmaceutical Investment Management Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Shanghai Shenqi Pharmaceutical Investment Management Co Interest Coverage Chart
Shanghai Shenqi Pharmaceutical Investment Management Co Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Shenqi Pharmaceutical Investment Management Co Interest Coverage vs Drug Manufacturers Industry
Shanghai Shenqi Pharmaceutical Investment Management Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) has a Interest Coverage of 11.03 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Shanghai Shenqi Pharmaceutical Investment Management Co and its competitors. This is near median its historical median of 10.75. Over the past decade, Shanghai Shenqi Pharmaceutical Investment Management Co's Interest Coverage has ranged from 2.29 to 43.45. According to the industry distribution chart, Shanghai Shenqi Pharmaceutical Investment Management Co ranks #361 out of 685 companies in the Drug Manufacturers industry, placing it in the top 52.7%.
Is Shanghai Shenqi Pharmaceutical Investment Management Co's Interest Coverage too high?
Shanghai Shenqi Pharmaceutical Investment Management Co's current Interest Coverage of 11.03 is near median its 10-year median of 10.75. Over the past 10 years, this metric has ranged from a low of 2.29 to a high of 43.45. The Drug Manufacturers industry median Interest Coverage is 12.75. Shanghai Shenqi Pharmaceutical Investment Management Co's value of 11.03 is 13.5% below this industry median. Based on the distribution chart, Shanghai Shenqi Pharmaceutical Investment Management Co ranks #361 out of 685 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Shanghai Shenqi Pharmaceutical Investment Management Co has a GF Score™ of 53/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Shenqi Pharmaceutical Investment Management Co's Interest Coverage compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Shanghai Shenqi Pharmaceutical Investment Management Co ranks #361 out of 685 companies for Interest Coverage. This places Shanghai Shenqi Pharmaceutical Investment Management Co in the lower half of its industry. The industry median Interest Coverage is 12.75. Shanghai Shenqi Pharmaceutical Investment Management Co's value of 11.03 is 13.5% below this benchmark. Historically, Shanghai Shenqi Pharmaceutical Investment Management Co's own Interest Coverage has ranged from 2.29 to 43.45 over the past decade. While the company's 10-year median is 10.75 vs. the industry median of 12.75, Shanghai Shenqi Pharmaceutical Investment Management Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.75, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Shenqi Pharmaceutical Investment Management Co's current Interest Coverage of 11.03 is 13.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Shanghai Shenqi Pharmaceutical Investment Management Co and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Shenqi Pharmaceutical Investment Management Co's current Interest Coverage is 11.03, which is near median its own 10-year median of 10.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Shenqi Pharmaceutical Investment Management Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥5.44, compared to a current price of ¥4.82 — trading 11.4% below its estimated fair value. The current Interest Coverage is 11.03, which is near median its 10-year median of 10.75 and 13.5% below the Drug Manufacturers industry median of 12.75. Shanghai Shenqi Pharmaceutical Investment Management Co's overall GF Score™ is 53/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613), the current Interest Coverage is 11.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Shenqi Pharmaceutical Investment Management Co stock appears to be undervalued.
The current stock price of ¥4.82 is trading 11.4% below its estimated GF Value™ of ¥5.44.
GuruFocus considers Shanghai Shenqi Pharmaceutical Investment Management Co to be Modestly Undervalued.
Key valuation signals for SHSE:600613:
Interest Coverage: 11.03 (near median its 10-year median of 10.75)
GF Value™: ¥5.44 vs. price of ¥4.82 (11.4% below fair value)
Industry Position: 13.5% below the Drug Manufacturers median (#361 of 685)
No single metric tells the full story. See the SHSE:600613 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Shenqi Pharmaceutical Investment Management Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600613 has been successfully added to your 
